Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease.

Taylor KM, Hanscombe KB, Prescott NJ, Iniesta R, Traylor M, Taylor NS, Fong S, Powell N, Irving PM, Anderson SH, Mathew CG, Lewis CM, Sanderson JD.

Clin Gastroenterol Hepatol. 2019 Jun 14. pii: S1542-3565(19)30643-3. doi: 10.1016/j.cgh.2019.05.061. [Epub ahead of print]

PMID:
31202982
2.

Reduced CD27-IgD- B Cells in Blood and Raised CD27-IgD- B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease.

Pararasa C, Zhang N, Tull TJ, Chong MHA, Siu JHY, Guesdon W, Chavele KM, Sanderson JD, Langmead L, Kok K, Spencer J, Vossenkamper A.

Front Immunol. 2019 Mar 5;10:361. doi: 10.3389/fimmu.2019.00361. eCollection 2019.

3.

Streptococcus Salivarius: A Potential Salivary Biomarker for Orofacial Granulomatosis and Crohn's Disease?

Goel RM, Prosdocimi EM, Amar A, Omar Y, Escudier MP, Sanderson JD, Wade WG, Prescott NJ.

Inflamm Bowel Dis. 2019 Jul 17;25(8):1367-1374. doi: 10.1093/ibd/izz022.

4.

Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD).

Blandford LE, Johnston EL, Sanderson JD, Wade WG, Lax AJ.

Gut Microbes. 2019 Feb 7:1-9. doi: 10.1080/19490976.2018.1560755. [Epub ahead of print]

PMID:
30732524
5.

Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study.

Samaan MA, Forsyth K, Segal JP, De Jong D, Vleugels JLA, Elkady S, Kabir M, Campbell S, Kok K, Armstrong DG, Penez L, Arenaza AP, Seward E, Vega R, Mehta S, Rahman F, McCartney S, Bloom S, Patel K, Pollok R, Westcott E, Darakhshan A, Williams A, Koumoutsos I, Ray S, Mawdsley J, Anderson S, Sanderson JD, Dekker E, D'Haens GR, Hart A, Irving PM.

J Crohns Colitis. 2019 May 27;13(6):735-743. doi: 10.1093/ecco-jcc/jjy225.

PMID:
30590513
6.

Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.

de Jong DC, Löwenberg M, Koumoutsos I, Ray S, Mawdsley J, Anderson S, Sanderson JD, Gecse K, Ponsioen CY, D'Haens GR, Irving PM, Samaan MA.

Inflamm Bowel Dis. 2019 Apr 11;25(5):937-944. doi: 10.1093/ibd/izy325.

PMID:
30329045
7.

Spatiotemporal segregation of human marginal zone and memory B cell populations in lymphoid tissue.

Zhao Y, Uduman M, Siu JHY, Tull TJ, Sanderson JD, Wu YB, Zhou JQ, Petrov N, Ellis R, Todd K, Chavele KM, Guesdon W, Vossenkamper A, Jassem W, D'Cruz DP, Fear DJ, John S, Scheel-Toellner D, Hopkins C, Moreno E, Woodman NL, Ciccarelli F, Heck S, Kleinstein SH, Bemark M, Spencer J.

Nat Commun. 2018 Sep 21;9(1):3857. doi: 10.1038/s41467-018-06089-1.

8.

Exome array analysis of adverse reactions to fluoropyrimidine-based therapy for gastrointestinal cancer.

Traylor M, Walker JL, Corrigan AA, Hernandez MA, Newhouse SJ, Folarin AA, Patel H, Ross PJ, Sanderson JD, Spicer J, Prescott NJ, Mathew CG, Marinaki AM, Lewis CM.

PLoS One. 2018 May 1;13(5):e0188911. doi: 10.1371/journal.pone.0188911. eCollection 2018.

9.

Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.

Hoyles L, Jiménez-Pranteda ML, Chilloux J, Brial F, Myridakis A, Aranias T, Magnan C, Gibson GR, Sanderson JD, Nicholson JK, Gauguier D, McCartney AL, Dumas ME.

Microbiome. 2018 Apr 20;6(1):73. doi: 10.1186/s40168-018-0461-0.

10.

Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.

de Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, Colombel JF, Lopez A, Beaugerie L, Marinaki AM, van Bodegraven AA, Neurath MF.

J Crohns Colitis. 2018 Apr 27;12(5):610-620. doi: 10.1093/ecco-jcc/jjx181. Review.

PMID:
29293971
11.

Exome Sequencing and Genotyping Identify a Rare Variant in NLRP7 Gene Associated With Ulcerative Colitis.

Onoufriadis A, Stone K, Katsiamides A, Amar A, Omar Y, de Lange KM, Taylor K, Barrett JC, Pollok R, Hayee B, Mansfield JC, Sanderson JD, Simpson MA, Mathew CG, Prescott NJ.

J Crohns Colitis. 2018 Feb 28;12(3):321-326. doi: 10.1093/ecco-jcc/jjx157.

12.

A Case of Unusual Ileal Discoloration.

Dhillon AS, Johnston EL, Sanderson JD.

Gastroenterology. 2018 Jul;155(1):e1-e2. doi: 10.1053/j.gastro.2017.09.043. Epub 2017 Oct 6. No abstract available.

PMID:
28989061
13.

Utilisation of anti-TNF levels in a UK tertiary IBD centre.

Johnston EL, Warner BD, Digby-Bell JL, Unsworth N, Anderson S, Sanderson JD, Arkir Z, Irving PM.

Frontline Gastroenterol. 2017 Jul;8(3):189-195. doi: 10.1136/flgastro-2016-100739. Epub 2016 Nov 29.

14.
15.

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety.

Ward MG, Patel KV, Kariyawasam VC, Goel R, Warner B, Elliott TR, Blaker PA, Irving PM, Marinaki AM, Sanderson JD.

United European Gastroenterol J. 2017 Jun;5(4):563-570. doi: 10.1177/2050640616663438. Epub 2016 Aug 1.

16.

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.

Ward MG, Warner B, Unsworth N, Chuah SW, Brownclarke C, Shieh S, Parkes M, Sanderson JD, Arkir Z, Reynolds J, Gibson PR, Irving PM.

Aliment Pharmacol Ther. 2017 Jul;46(2):150-161. doi: 10.1111/apt.14124. Epub 2017 May 8.

17.

Patient optimization for surgery relating to Crohn's disease.

Patel KV, Darakhshan AA, Griffin N, Williams AB, Sanderson JD, Irving PM.

Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):707-719. doi: 10.1038/nrgastro.2016.158. Epub 2016 Oct 26. Review.

PMID:
27780971
18.

Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis.

Mentzer A, Nayee S, Omar Y, Hullah E, Taylor K, Goel R, Bye H, Shembesh T, Elliott TR, Campbell H, Patel P, Nolan A, Mansfield J, Challacombe S, Escudier M, Mathew CG, Sanderson JD, Prescott NJ.

Inflamm Bowel Dis. 2016 Jul;22(7):1552-8. doi: 10.1097/MIB.0000000000000844.

19.

Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.

Meulendijks D, Henricks LM, Sonke GS, Deenen MJ, Froehlich TK, Amstutz U, Largiadèr CR, Jennings BA, Marinaki AM, Sanderson JD, Kleibl Z, Kleiblova P, Schwab M, Zanger UM, Palles C, Tomlinson I, Gross E, van Kuilenburg AB, Punt CJ, Koopman M, Beijnen JH, Cats A, Schellens JH.

Lancet Oncol. 2015 Dec;16(16):1639-50. doi: 10.1016/S1470-2045(15)00286-7. Epub 2015 Oct 23. Review.

PMID:
26603945
20.

Azathioprine is effective for oral involvement in Crohn's disease but not for orofacial granulomatosis alone.

Mentzer A, Goel R, Elliott T, Campbell H, Hullah E, Patel P, Challacombe S, Escudier M, Sanderson JD.

J Oral Pathol Med. 2016 Apr;45(4):312-8. doi: 10.1111/jop.12379. Epub 2015 Nov 23.

PMID:
26593695
21.

TPMT Testing Before Starting Azathioprine or Mercaptopurine: Surely Just Do It?

Sanderson JD.

Gastroenterology. 2015 Oct;149(4):850-3. doi: 10.1053/j.gastro.2015.08.040. Epub 2015 Aug 24. No abstract available.

PMID:
26311276
22.

Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease.

Ward MG, Kariyawasam VC, Mogan SB, Patel KV, Pantelidou M, Sobczyńska-Malefora A, Porté F, Griffin N, Anderson SH, Sanderson JD, Harrington DJ, Irving PM.

Inflamm Bowel Dis. 2015 Dec;21(12):2839-47. doi: 10.1097/MIB.0000000000000559.

PMID:
26296064
23.

The causes of oral ulcer-action are legion.

Goel RM, Ormond M, Nayee S, Hullah EA, Sanderson JD, Escudier M.

Br J Hosp Med (Lond). 2015 Aug;76(8):488. doi: 10.12968/hmed.2015.76.8.442. No abstract available.

PMID:
26255912
24.

Klebsiella pneumoniae subsp. pneumoniae-bacteriophage combination from the caecal effluent of a healthy woman.

Hoyles L, Murphy J, Neve H, Heller KJ, Turton JF, Mahony J, Sanderson JD, Hudspith B, Gibson GR, McCartney AL, van Sinderen D.

PeerJ. 2015 Jul 28;3:e1061. doi: 10.7717/peerj.1061. eCollection 2015.

25.

Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease.

Elliott TR, Rayment NB, Hudspith BN, Hands RE, Taylor K, Parkes GC, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Bustin SA, Sanderson JD.

BMC Gastroenterol. 2015 Jul 3;15:75. doi: 10.1186/s12876-015-0305-3.

26.

A guide to oral ulceration for the medical physician.

Goel RM, Ormond M, Nayee S, Hullah EA, Sanderson JD, Escudier M.

Br J Hosp Med (Lond). 2015 Jun;76(6):337-42. doi: 10.12968/hmed.2015.76.6.337.

PMID:
26053904
27.

Optimizing the use of thiopurines in inflammatory bowel disease.

Goel RM, Blaker P, Mentzer A, Fong SC, Marinaki AM, Sanderson JD.

Ther Adv Chronic Dis. 2015 May;6(3):138-46. doi: 10.1177/2040622315579063. Review.

28.

Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.

Powell N, Lo JW, Biancheri P, Vossenkämper A, Pantazi E, Walker AW, Stolarczyk E, Ammoscato F, Goldberg R, Scott P, Canavan JB, Perucha E, Garrido-Mesa N, Irving PM, Sanderson JD, Hayee B, Howard JK, Parkhill J, MacDonald TT, Lord GM.

Gastroenterology. 2015 Aug;149(2):456-67.e15. doi: 10.1053/j.gastro.2015.04.017. Epub 2015 Apr 25.

29.

Defective macrophage handling of Escherichia coli in Crohn's disease.

Elliott TR, Hudspith BN, Rayment NB, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Sanderson JD.

J Gastroenterol Hepatol. 2015 Aug;30(8):1265-74. doi: 10.1111/jgh.12955.

PMID:
25809337
30.

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.

Canavan JB, Scottà C, Vossenkämper A, Goldberg R, Elder MJ, Shoval I, Marks E, Stolarczyk E, Lo JW, Powell N, Fazekasova H, Irving PM, Sanderson JD, Howard JK, Yagel S, Afzali B, MacDonald TT, Hernandez-Fuentes MP, Shpigel NY, Lombardi G, Lord GM.

Gut. 2016 Apr;65(4):584-94. doi: 10.1136/gutjnl-2014-306919. Epub 2015 Feb 24.

31.

Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond.

Fong SC, Blaker PA, Arenas-Hernandez M, Marinaki AM, Sanderson JD.

Biomark Med. 2015;9(1):51-65. doi: 10.2217/bmm.14.97. Review.

PMID:
25605455
32.

A practical guide to the use of thiopurines in oral medicine.

Hullah EA, Blaker PA, Marinaki AM, Escudier MP, Sanderson JD.

J Oral Pathol Med. 2015 Nov;44(10):761-8. doi: 10.1111/jop.12274. Epub 2014 Dec 19. Review.

PMID:
25529219
33.

Characterization of virus-like particles associated with the human faecal and caecal microbiota.

Hoyles L, McCartney AL, Neve H, Gibson GR, Sanderson JD, Heller KJ, van Sinderen D.

Res Microbiol. 2014 Dec;165(10):803-12. doi: 10.1016/j.resmic.2014.10.006. Epub 2014 Oct 22.

34.

Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations.

Corrigan A, Walker JL, Wickramasinghe S, Hernandez MA, Newhouse SJ, Folarin AA, Lewis CM, Sanderson JD, Spicer J, Marinaki AM.

Pharmacogenomics J. 2014 Oct;14(5):411-7. doi: 10.1038/tpj.2014.13. Epub 2014 Apr 15.

PMID:
24732178
35.

Early use of azathioprine in Crohn's disease.

Hawthorne AB, Probert CS, Sanderson JD.

Gastroenterology. 2014 Mar;146(3):865-6. doi: 10.1053/j.gastro.2013.10.072. Epub 2014 Jan 24. No abstract available.

PMID:
24468182
36.

Reply to Dr. Marques do Santos' letter - should we treat asymptomatic patients with mildly ulcerated terminal ileum?

Patel KV, Anderson SH, Sanderson JD.

J Crohns Colitis. 2014 May;8(5):438. doi: 10.1016/j.crohns.2013.11.012. Epub 2013 Dec 4. No abstract available.

PMID:
24314628
37.

Oesophageal Crohn's disease: a novel approach to managing iatrogenic perforation of an oesophageal Crohn's stricture.

Patel KV, Irving PM, Sanderson JD.

J Crohns Colitis. 2014 Apr;8(4):332-3. doi: 10.1016/j.crohns.2013.11.002. Epub 2013 Nov 20. No abstract available.

PMID:
24268979
38.

Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.

Elliott TR, Hudspith BN, Wu G, Cooley M, Parkes G, Quiñones B, Randall L, Mandrell RE, Fagerquist CK, Brostoff J, Rayment NB, Boussioutas A, Petrovska L, Sanderson JD.

Inflamm Bowel Dis. 2013 Oct;19(11):2326-38. doi: 10.1097/MIB.0b013e3182a38a92.

PMID:
23989750
39.

A role for gut-associated lymphoid tissue in shaping the human B cell repertoire.

Vossenkämper A, Blair PA, Safinia N, Fraser LD, Das L, Sanders TJ, Stagg AJ, Sanderson JD, Taylor K, Chang F, Choong LM, D'Cruz DP, Macdonald TT, Lombardi G, Spencer J.

J Exp Med. 2013 Aug 26;210(9):1665-74. doi: 10.1084/jem.20122465. Epub 2013 Aug 12.

40.

Mechanism of allopurinol induced TPMT inhibition.

Blaker PA, Arenas-Hernandez M, Smith MA, Shobowale-Bakre EA, Fairbanks L, Irving PM, Sanderson JD, Marinaki AM.

Biochem Pharmacol. 2013 Aug 15;86(4):539-47. doi: 10.1016/j.bcp.2013.06.002. Epub 2013 Jun 14.

PMID:
23770457
41.

Alopecia areata: a possible extraintestinal manifestation of Crohn's disease.

Patel KV, Sanderson JD, Irving PM.

J Crohns Colitis. 2013 Nov;7(10):e503. doi: 10.1016/j.crohns.2013.05.004. Epub 2013 Jun 3. No abstract available.

PMID:
23742938
42.

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.

Loganayagam A, Arenas Hernandez M, Corrigan A, Fairbanks L, Lewis CM, Harper P, Maisey N, Ross P, Sanderson JD, Marinaki AM.

Br J Cancer. 2013 Jun 25;108(12):2505-15. doi: 10.1038/bjc.2013.262. Epub 2013 Jun 4.

43.

Hair loss in patients with inflammatory bowel disease.

Patel KV, Farrant P, Sanderson JD, Irving PM.

Inflamm Bowel Dis. 2013 Jul;19(8):1753-63. doi: 10.1097/MIB.0b013e31828132de. Review.

PMID:
23624889
44.

Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies.

Ellinghaus D, Zhang H, Zeissig S, Lipinski S, Till A, Jiang T, Stade B, Bromberg Y, Ellinghaus E, Keller A, Rivas MA, Skieceviciene J, Doncheva NT, Liu X, Liu Q, Jiang F, Forster M, Mayr G, Albrecht M, Häsler R, Boehm BO, Goodall J, Berzuini CR, Lee J, Andersen V, Vogel U, Kupcinskas L, Kayser M, Krawczak M, Nikolaus S, Weersma RK, Ponsioen CY, Sans M, Wijmenga C, Strachan DP, McArdle WL, Vermeire S, Rutgeerts P, Sanderson JD, Mathew CG, Vatn MH, Wang J, Nöthen MM, Duerr RH, Büning C, Brand S, Glas J, Winkelmann J, Illig T, Latiano A, Annese V, Halfvarson J, D'Amato M, Daly MJ, Nothnagel M, Karlsen TH, Subramani S, Rosenstiel P, Schreiber S, Parkes M, Franke A.

Gastroenterology. 2013 Aug;145(2):339-47. doi: 10.1053/j.gastro.2013.04.040. Epub 2013 Apr 25.

45.

Development of a low phenolic acid diet for the management of orofacial granulomatosis.

Campbell HE, Escudier MP, Milligan P, Challacombe SJ, Sanderson JD, Lomer MC.

J Hum Nutr Diet. 2013 Dec;26(6):527-37. doi: 10.1111/jhn.12046. Epub 2013 Apr 10.

PMID:
23574355
46.

Factors affecting decision making in Hispanics experiencing myocardial infarction.

Sanderson JD.

J Transcult Nurs. 2013 Apr;24(2):117-26. doi: 10.1177/1043659612472062. Epub 2013 Jan 22. Review.

PMID:
23341409
47.

Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach?

Campbell H, Escudier MP, Brostoff J, Patel P, Milligan P, Challacombe SJ, Sanderson JD, Lomer MC.

J Oral Pathol Med. 2013 Aug;42(7):517-22. doi: 10.1111/jop.12041. Epub 2013 Jan 9.

PMID:
23297760
48.

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH.

Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582.

49.

The pharmacogenetic basis of individual variation in thiopurine metabolism.

Blaker PA, Arenas-Hernandez M, Marinaki AM, Sanderson JD.

Per Med. 2012 Sep;9(7):707-725. doi: 10.2217/pme.12.85.

PMID:
29776272
50.

Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis.

Lee LY, Sanderson JD, Irving PM.

Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1078-85. doi: 10.1097/MEG.0b013e32835558cf.

PMID:
22647738

Supplemental Content

Loading ...
Support Center